rel-Delequamine
rel-Delequamine (rel-RS-15385-197) is an orally active, brain-penetrant, potent and selective M2-adrenoceptor antagonist and α2-adrenoceptor antagonist. rel-Delequamine has a pKi of 9.45 for α2-adrenoceptors in the rat cortex. rel-Delequamine augments K+-evoked release of noradrenaline with an EC50 of 1 nM.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 119813-87-5
- Formule: C18H26N2O3S
- Masse moléculaire:350.48
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform Adrenergic Receptor
More
Activité biologique
Chemical Information
-
CAS No. 119813-87-5
-
Masse moléculaire 350.48
-
Formule C18H26N2O3S
-
SMILES
O=S(N1CCC[C@@]2(CN([C@]3(C[C@]12[H])[H])CCC4=C3C=CC(OC)=C4)[H])(C)=O
-
Synonyms
rel-RS-15385-197
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Brown CM, et al. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist. Br J Pharmacol. 1993 Feb;108(2):516-25. [Content Brief]
[2]. Redfern WS, et al. Modulation of central noradrenergic function by RS-15385-197. Br J Pharmacol. 1993 Feb;108(2):526-33. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)